Publications by Børre Fevang

72 publications found

Publications 2024

1. De Bortoli A, Nordøy I, Connelly JP, Viermyr HK, Bjerkreim RH, Broch K, Olsen PAS, Gude E, Fevang B, Jørgensen SF, Trøseid M, Steen T, Aukrust P, Andreassen AK, Skarpengland T (2024)
   Diagnostics, treatment and outcomes of cardiac sarcoidosis in a Norwegian cohort
   Int J Cardiol, 400, 131809
   DOI 10.1016/j.ijcard.2024.131809, PubMed 38272129
2. Skudal H, Lorentzen ÅR, Stenstad T, Quist-Paulsen E, Egeland J, Fevang B, Jaioun K, Hansen BÅ, Solheim AM, Tveten Y, Veje M, Eikeland R, Kersten H (2024)
   Clinical characteristics and factors affecting disease severity in hospitalized tick-borne encephalitis patients in Norway from 2018 to 2022
   Eur J Clin Microbiol Infect Dis (in press)
   DOI 10.1007/s10096-024-04855-2, PubMed 38801484
3. Yang M, Kaarbø M, Myhre V, Reims HM, Karlsen TH, Wang J, Rognes T, Halvorsen B, Fevang B, Lundin KEA, Aukrust P, Bjørås M, Jørgensen SF (2024)
   Altered Genome-Wide DNA Methylation in the Duodenum of Common Variable Immunodeficiency Patients
   J Clin Immunol, 44 (6), 133
   DOI 10.1007/s10875-024-01726-5, PubMed 38780872

Publications 2023

1. Andersen IM, Reims HM, Grzyb K, Fevang B, Melum E, Aukrust P, Wiencke K, Nordøy I, Line PD, Jørgensen SF (2023)
   Long-term survival after liver transplantation in patients with common variable immunodeficiency
   Liver Transpl, 29 (8), 894-899
   DOI 10.1097/LVT.0000000000000130, PubMed 36932715
2. Bintalib HM, van de Ven A, Jacob J, Davidsen JR, Fevang B, Hanitsch LG, Malphettes M, van Montfrans J, Maglione PJ, Milito C, Routes J, Warnatz K, Hurst JR (2023)
   Diagnostic testing for interstitial lung disease in common variable immunodeficiency: a systematic review
   Front Immunol, 14, 1190235
   DOI 10.3389/fimmu.2023.1190235, PubMed 37223103
3. Fevang B (2023)
   Treatment of inflammatory complications in common variable immunodeficiency (CVID): current concepts and future perspectives
   Expert Rev Clin Immunol, 19 (6), 627-638
   DOI 10.1080/1744666X.2023.2198208, PubMed 36996348
4. Jorgensen SF, Macpherson ME, Skarpengland T, Berge RK, Fevang B, Halvorsen B, Aukrust P (2023)
   Disturbed lipid profile in common variable immunodeficiency - a pathogenic loop of inflammation and metabolic disturbances
   Front Immunol, 14, 1199727
   DOI 10.3389/fimmu.2023.1199727, PubMed 37545531
5. Løken RØ, Fevang B (2023)
   Cellular immunity in COVID-19 and other infections in Common variable immunodeficiency
   Front Immunol, 14, 1124279
   DOI 10.3389/fimmu.2023.1124279, PubMed 37180118
6. Macpherson ME, Skarpengland T, Hov JR, Ranheim T, Vestad B, Dahl TB, Fraz MSA, Michelsen AE, Holven KB, Fevang B, Berge RK, Aukrust P, Halvorsen B, Jørgensen SF (2023)
   Increased Plasma Levels of Triglyceride-Enriched Lipoproteins Associate with Systemic Inflammation, Lipopolysaccharides, and Gut Dysbiosis in Common Variable Immunodeficiency
   J Clin Immunol, 43 (6), 1229-1240
   DOI 10.1007/s10875-023-01475-x, PubMed 36995502
7. Nissen-Meyer LSH, Macpherson ME, Skeie LG, Hvalryg M, Llohn AH, Steinsvåg TT, Fenstad MH, Tveita A, Kristoffersen EK, Sundic T, Lund-Johansen F, Vaage JT, Flesland Ø, Dyrhol-Riise AM, Holter JC, Hervig TA, Fevang B (2023)
   COVID-19 patients treated with convalescent plasma
   Tidsskr Nor Laegeforen, 143 (11)
   DOI 10.4045/tidsskr.22.0577, PubMed 37589359

Publications 2022

1. Fraz MSA, Michelsen AE, Moe N, Aaløkken TM, Macpherson ME, Nordøy I, Aukrust P, Taraldsrud E, Holm AM, Ueland T, Jørgensen SF, Fevang B (2022)
   Raised Serum Markers of T Cell Activation and Exhaustion in Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency
   J Clin Immunol, 42 (7), 1553-1563
   DOI 10.1007/s10875-022-01318-1, PubMed 35789314
2. Granerud BK, Ueland T, Lind A, Søraas A, Fevang B, Steffensen AK, Al-Baldawi H, Lund-Johansen F, Aukrust P, Halvorsen B, Dahl TB, Dudman S, Müller F, Holter JC (2022)
   Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
   Viruses, 14 (11)
   DOI 10.3390/v14112420, PubMed 36366518
3. Kaarbø M, Yang M, Hov JR, Holm K, de Sousa MML, Macpherson ME, Reims HM, Kran AB, Halvorsen B, Karlsen TH, Aukrust P, Lundin KEA, Fevang B, Bjørås M, Jørgensen SF (2022)
   Duodenal inflammation in common variable immunodeficiency has altered transcriptional response to viruses
   J Allergy Clin Immunol, 151 (3), 767-777
   DOI 10.1016/j.jaci.2022.09.029, PubMed 36220400
4. Lévy R, Gothe F, Momenilandi M, Magg T, Materna M, Peters P, Raedler J, Philippot Q, Rack-Hoch AL, Langlais D, Bourgey M, Lanz AL, Ogishi M, Rosain J, Martin E, Latour S, Vladikine N, Distefano M, Khan T, Rapaport F, Schulz MS, Holzer U, Fasth A, Sogkas G, Speckmann C et al. (2022)
   Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
   J Exp Med, 220 (2)
   DOI 10.1084/jem.20220275, PubMed 36515678
5. Nissen-Meyer LSH, Hervig T, Fevang B, Norheim G, Kran AB, Vaage JT, Flesland Ø (2022)
   COVID-19 convalescent plasma from Norwegian blood donors
   Tidsskr Nor Laegeforen, 142 (9)
   DOI 10.4045/tidsskr.22.0057, PubMed 35699539
6. Søraas A, Grødeland G, Granerud BK, Ueland T, Lind A, Fevang B, Murphy SL, Huse C, Nygaard AB, Steffensen AK, Al-Baldawi H, Holberg-Petersen M, Andresen LL, Ågnes C, Ranheim T, Schanke Y, Istre M, Dahl JA, Chopra A, Dudman S, Kaarbø M, Andersen JT, Vaage EB, Tran TT, Vaage JT et al. (2022)
   Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
   Front Immunol, 13, 964525
   DOI 10.3389/fimmu.2022.964525, PubMed 36159859
7. Trøseid M, Dahl TB, Holter JC, Kildal AB, Murphy SL, Yang K, Quiles-Jiménez A, Heggelund L, Müller KE, Tveita A, Michelsen AE, Bøe S, Holten AR, Hoel H, Mathiessen A, Aaløkken TM, Fevang B, Granerud BK, Tonby K, Henriksen KN, Lerum TV, Müller F, Skjønsberg OH, Barratt-Due A, Dyrhol-Riise AM et al. (2022)
   Persistent T-cell exhaustion in relation to prolonged pulmonary pathology and death after severe COVID-19: Results from two Norwegian cohort studies
   J Intern Med, 292 (5), 816-828
   DOI 10.1111/joim.13549, PubMed 35982589
8. Tveita A, Murphy SL, Holter JC, Kildal AB, Michelsen AE, Lerum TV, Kaarbø M, Heggelund L, Holten AR, Finbråten AK, Müller KE, Mathiessen A, Bøe S, Fevang B, Granerud BK, Tonby K, Lind A, Dudman SG, Henriksen KN, Müller F, Skjønsberg OH, Trøseid M, Barratt-Due A, Dyrhol-Riise AM, Aukrust P et al. (2022)
   High Circulating Levels of the Homeostatic Chemokines CCL19 and CCL21 Predict Mortality and Disease Severity in COVID-19
   J Infect Dis, 226 (12), 2150-2160
   DOI 10.1093/infdis/jiac313, PubMed 35876699

Publications 2021

1. Fevang B, Warnatz K, Hurst JR (2021)
   Editorial: Interstitial Lung Disease in Primary Immunodeficiencies
   Front Immunol, 12, 699126
   DOI 10.3389/fimmu.2021.699126, PubMed 34305936
2. Fevang B, Wyller VBB, Mollnes TE, Pedersen M, Asprusten TT, Michelsen A, Ueland T, Otterdal K (2021)
   Lasting Immunological Imprint of Primary Epstein-Barr Virus Infection With Associations to Chronic Low-Grade Inflammation and Fatigue
   Front Immunol, 12, 715102
   DOI 10.3389/fimmu.2021.715102, PubMed 34987499
3. Fraz MSA, Moe N, Revheim ME, Stavrinou ML, Durheim MT, Nordøy I, Macpherson ME, Aukrust P, Jørgensen SF, Aaløkken TM, Fevang B (2021)
   Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and ¹⁸F-FDG Positron Emission Tomography/CT in Clinically Progressive Disease
   Front Immunol, 11, 617985
   DOI 10.3389/fimmu.2020.617985, PubMed 33584710
4. Hurst JR, Abbas SH, Bintalib HM, Alfaro TM, Baumann U, Burns SO, Condliffe A, Davidsen JR, Fevang B, Gennery AR, Haerynck F, Jacob J, Jolles S, Lamers O, Bergeron A, Malphettes M, Meignin V, Milito C, Milota T, Pergent M, Prasse A, Quinti I, Renzoni E, Sediva A, Stolz D et al. (2021)
   Granulomatous-lymphocytic interstitial lung disease: an international research prioritisation
   ERJ Open Res, 7 (4)
   DOI 10.1183/23120541.00467-2021, PubMed 34881327
5. Hustad NB, Degerud HM, Hjelmerud I, Fraz MSA, Nordøy I, Trøseid M, Fevang B, Aukrust P, Jørgensen SF (2021)
   Real-World Experiences With Facilitated Subcutaneous Immunoglobulin Substitution in Patients With Hypogammaglobulinemia, Using a Three-Step Ramp-Up Schedule
   Front Immunol, 12, 670547
   DOI 10.3389/fimmu.2021.670547, PubMed 34012453
6. Jørgensen SF, Buechner J, Myhre AE, Galteland E, Spetalen S, Kulseth MA, Sorte HS, Holla ØL, Lundman E, Alme C, Heier I, Flægstad T, Fløisand Y, Benneche A, Fevang B, Aukrust P, Stray-Pedersen A, Gedde-Dahl T, Nordøy I (2021)
   A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT
   J Clin Immunol, 42 (2), 404-420
   DOI 10.1007/s10875-021-01189-y, PubMed 34893945
7. Skarpengland T, Macpherson ME, Hov JR, Kong XY, Bohov P, Halvorsen B, Fevang B, Berge RK, Aukrust P, Jørgensen SF (2021)
   Altered Plasma Fatty Acids Associate with Gut Microbial Composition in Common Variable Immunodeficiency
   J Clin Immunol, 42 (1), 146-157
   DOI 10.1007/s10875-021-01146-9, PubMed 34669143

Publications 2020

1. Holter JC, Pischke SE, de Boer E, Lind A, Jenum S, Holten AR, Tonby K, Barratt-Due A, Sokolova M, Schjalm C, Chaban V, Kolderup A, Tran T, Tollefsrud Gjølberg T, Skeie LG, Hesstvedt L, Ormåsen V, Fevang B, Austad C, Müller KE, Fladeby C, Holberg-Petersen M, Halvorsen B, Müller F, Aukrust P et al. (2020)
   Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
   Proc Natl Acad Sci U S A, 117 (40), 25018-25025
   DOI 10.1073/pnas.2010540117, PubMed 32943538
2. Jørgensen SF, Fevang B, Aukrust P (2020)
   Commentary: Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy
   Front Immunol, 11, 1921
   DOI 10.3389/fimmu.2020.01921, PubMed 32983117
3. Macpherson ME, Hov JR, Ueland T, Dahl TB, Kummen M, Otterdal K, Holm K, Berge RK, Mollnes TE, Trøseid M, Halvorsen B, Aukrust P, Fevang B, Jørgensen SF (2020)
   Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency
   Front Immunol, 11, 574500
   DOI 10.3389/fimmu.2020.574500, PubMed 33042155
4. Nordøy I, Fraz MAS, Trøseid M, Fevang B, Aukrust P (2020)
   [Elevated serum ferritin is not only a sign of liver failure]
   Tidsskr Nor Laegeforen, 140 (8)
   DOI 10.4045/tidsskr.20.0376, PubMed 32463199
5. Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jørgensen MJ, Barratt-Due A, Skeie LG, Nordøy I, Aanensen Fraz MS, Quist-Paulsen E E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Müller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM et al. (2020)
   Elevated plasma sTIM-3 levels in patients with severe COVID-19
   J Allergy Clin Immunol, 147 (1), 92-98
   DOI 10.1016/j.jaci.2020.09.007, PubMed 32971109
6. van de Ven AAJM, Alfaro TM, Robinson A, Baumann U, Bergeron A, Burns SO, Condliffe AM, Fevang B, Gennery AR, Haerynck F, Jacob J, Jolles S, Malphettes M, Meignin V, Milota T, van Montfrans J, Prasse A, Quinti I, Renzoni E, Stolz D, Warnatz K, Hurst JR (2020)
   Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey
   Front Immunol, 11, 606333
   DOI 10.3389/fimmu.2020.606333, PubMed 33324422

Publications 2019

1. Holmøy T, Fevang B, Olsen DB, Spigset O, Bø L (2019)
   Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
   BMC Res Notes, 12 (1), 497
   DOI 10.1186/s13104-019-4507-6, PubMed 31405369
2. Jørgensen SF, Holm K, Macpherson ME, Storm-Larsen C, Kummen M, Fevang B, Aukrust P, Hov JR (2019)
   Selective IgA deficiency in humans is associated with reduced gut microbial diversity
   J Allergy Clin Immunol, 143 (5), 1969-1971.e11
   DOI 10.1016/j.jaci.2019.01.019, PubMed 30707969
3. Jørgensen SF, Macpherson ME, Bjørnetrø T, Holm K, Kummen M, Rashidi A, Michelsen AE, Lekva T, Halvorsen B, Trøseid M, Mollnes TE, Berge RK, Yndestad A, Ueland T, Karlsen TH, Aukrust P, Hov JR, Fevang B (2019)
   Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency
   Sci Rep, 9 (1), 167 (Retracted)
   DOI 10.1038/s41598-018-35367-7, PubMed 30655568
4. Macpherson ME, Halvorsen B, Yndestad A, Ueland T, Mollnes TE, Berge RK, Rashidi A, Otterdal K, Gregersen I, Kong XY, Holven KB, Aukrust P, Fevang B, Jørgensen SF (2019)
   Impaired HDL Function Amplifies Systemic Inflammation in Common Variable Immunodeficiency
   Sci Rep, 9 (1), 9427
   DOI 10.1038/s41598-019-45861-1, PubMed 31263122

Publications 2018

1. Fevang B (2018)
   [Not Available]
   Tidsskr Nor Laegeforen, 138 (2)
   DOI 10.4045/tidsskr.18.0019, PubMed 29357620
2. Fevang B (2018)
   Open access- elephant (or polar bear) in the room
   Tidsskr. Nor. Laegeforen., 138 (2), 110
3. Fevang B, Fagerli UM, Sorte H, Aarset H, Hov H, Langmyr M, Keil TM, Bjørge E, Aukrust P, Stray-Pedersen A, Gedde-Dahl T (2018)
   Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas
   Case Reports Immunol, 2018, 2053716
   DOI 10.1155/2018/2053716, PubMed 29888014
4. Fevang P, Havemann K, Fevang B, Høstmark AT (2018)
   Malaria and Malnutrition: Kwashiorkor Associated with Low Levels of Parasitaemia
   Malar Res Treat, 2018, 7153173
   DOI 10.1155/2018/7153173, PubMed 30533212
5. Jørgensen SF, Fevang B, Aukrust P (2018)
   Autoimmunity and Inflammation in CVID: a Possible Crosstalk between Immune Activation, Gut Microbiota, and Epigenetic Modifications
   J Clin Immunol, 39 (1), 30-36
   DOI 10.1007/s10875-018-0574-z, PubMed 30465180
6. Nordheim E, Olafsson Storrø M, Natvik AK, Birkeland Kro G, Midtvedt K, Varberg Reisaeter A, Hagness M, Fevang B, Pettersen FO (2018)
   Donor-derived strongyloidiasis after organ transplantation in Norway
   Transpl Infect Dis, 21 (1), e13008
   DOI 10.1111/tid.13008, PubMed 30295406
7. Otterdal K, Berg A, Michelsen AE, Patel S, Tellevik MG, Haanshuus CG, Fevang B, Aukrust P, Langeland N, Ueland T (2018)
   Soluble markers of neutrophil, T-cell and monocyte activation are associated with disease severity and parasitemia in falciparum malaria
   BMC Infect Dis, 18 (1), 670
   DOI 10.1186/s12879-018-3593-8, PubMed 30563486
8. Troseid M, Nordoy I, Fevang B, Aukrust P (2018)
   Tenders for HIV medicines are not academically justified
   Tidsskr. Nor. Laegeforen., 138 (20), 1912-1913
9. Trøseid M, Nordøy I, Fevang B, Aukrust P (2018)
   [Tendering for HIV drugs is not clinically justified]
   Tidsskr Nor Laegeforen, 138 (20)
   DOI 10.4045/tidsskr.18.0808, PubMed 30539614

Publications 2017

1. Fevang B (2017)
   [Not Available]
   Tidsskr Nor Laegeforen, 137 (23-24)
   DOI 10.4045/tidsskr.17.1010, PubMed 29231632
2. Fevang B (2017)
   Open access- elephant (or polar bear) in the room
   Tidsskr. Nor. Laegeforen., 137 (23-24), 1860
3. Holm KL, Syljuåsen RG, Hasvold G, Alsøe L, Nilsen H, Ivanauskiene K, Collas P, Shaposhnikov S, Collins A, Indrevær RL, Aukrust P, Fevang B, Blomhoff HK (2017)
   TLR9 stimulation of B-cells induces transcription of p53 and prevents spontaneous and irradiation-induced cell death independent of DNA damage responses. Implications for Common variable immunodeficiency
   PLoS One, 12 (10), e0185708
   DOI 10.1371/journal.pone.0185708, PubMed 28973009
4. Jørgensen SF, Reims HM, Aukrust P, Lundin KE, Fevang B (2017)
   CVID and Celiac Disease
   Am J Gastroenterol, 112 (2), 393
   DOI 10.1038/ajg.2016.551, PubMed 28154406
5. Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíc Ková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T (2017)
   Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
   Sci Rep, 7, 39710
   DOI 10.1038/srep39710, PubMed 28054583
6. Stuchlý J, Kanderová V, Vlková M, Heřmanová I, Slámová L, Pelák O, Taraldsrud E, Jílek D, Králíčková P, Fevang B, Trková M, Hrušák O, Froňková E, Šedivá A, Litzman J, Kalina T (2017)
   Erratum: Common Variable Immunodeficiency patients with a phenotypic profile of immunosenescence present with thrombocytopenia
   Sci Rep, 7, 42569
   DOI 10.1038/srep42569, PubMed 28240280
7. Taraldsrud E, Fevang B, Jørgensen SF, Moltu K, Hilden V, Taskén K, Aukrust P, Myklebust JH, Olweus J (2017)
   Defective IL-4 signaling in T cells defines severe common variable immunodeficiency
   J Autoimmun, 81, 110-119
   DOI 10.1016/j.jaut.2017.04.004, PubMed 28476239
8. Vikum D, Nordøy I, Torp Andersen C, Fevang B, Line PD, Kolrud FK, Aukrust P, Buanes T (2017)
   A Young, Immunocompetent Woman with Small Bowel and Hepatic Mucormycosis Successfully Treated with Aggressive Surgical Debridements and Antifungal Therapy
   Case Rep Infect Dis, 2017, 4173246
   DOI 10.1155/2017/4173246, PubMed 29435377

Publications 2016

1. Falkenberg-Jensen B, Aaløkken TM, Fevang B (2016)
   [Atypical mycobacteria and Lady Windermere]
   Tidsskr Nor Laegeforen, 136 (14-15), 1227
   DOI 10.4045/tidsskr.16.0235, PubMed 27554564
2. Jørgensen SF, Macpherson ME, Bjøro K, Karlsen TH, Reims HM, Grzyb K, Fosby B, Fevang B, Aukrust P, Nordøy I (2016)
   Liver transplantation in patients with primary antibody deficiency
   J Allergy Clin Immunol, 139 (5), 1708-1710.e2
   DOI 10.1016/j.jaci.2016.10.025, PubMed 27931972
3. Jørgensen SF, Reims HM, Frydenlund D, Holm K, Paulsen V, Michelsen AE, Jørgensen KK, Osnes LT, Bratlie J, Eide TJ, Dahl CP, Holter E, Tronstad RR, Hanevik K, Brattbakk HR, Kaveh F, Fiskerstrand T, Kran AB, Ueland T, Karlsen TH, Aukrust P, Lundin KE, Fevang B (2016)
   A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
   Am J Gastroenterol, 111 (10), 1467-1475
   DOI 10.1038/ajg.2016.329, PubMed 27527747
4. Jørgensen SF, Trøseid M, Kummen M, Anmarkrud JA, Michelsen AE, Osnes LT, Holm K, Høivik ML, Rashidi A, Dahl CP, Vesterhus M, Halvorsen B, Mollnes TE, Berge RK, Moum B, Lundin KE, Fevang B, Ueland T, Karlsen TH, Aukrust P, Hov JR (2016)
   Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation
   Mucosal Immunol, 9 (6), 1455-1465
   DOI 10.1038/mi.2016.18, PubMed 26982597
5. Sorte HS, Osnes LT, Fevang B, Aukrust P, Erichsen HC, Backe PH, Abrahamsen TG, Kittang OB, Øverland T, Jhangiani SN, Muzny DM, Vigeland MD, Samarakoon P, Gambin T, Akdemir ZH, Gibbs RA, Rødningen OK, Lyle R, Lupski JR, Stray-Pedersen A (2016)
   A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T-cell dysfunction
   Mol Genet Genomic Med, 4 (6), 604-616
   DOI 10.1002/mgg3.237, PubMed 27896283
6. Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis CM, Canter DL, Mace EM, Vece TJ, Allen CE, Abhyankar HA, Boone PM, Beck CR et al. (2016)
   Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
   J Allergy Clin Immunol, 139 (1), 232-245
   DOI 10.1016/j.jaci.2016.05.042, PubMed 27577878
7. Taraldsrud E, Aukrust P, Jørgensen S, Lingjærde OC, Olweus J, Myklebust JH, Fevang B (2016)
   Patterns of constitutively phosphorylated kinases in B cells are associated with disease severity in common variable immunodeficiency
   Clin Immunol, 175, 69-74
   DOI 10.1016/j.clim.2016.11.014, PubMed 27919819

Publications 2015

1. Indrevær RL, Moskaug JØ, Paur I, Bøhn SK, Jørgensen SF, Blomhoff R, Aukrust P, Fevang B, Blomhoff HK (2015)
   IRF4 Is a Critical Gene in Retinoic Acid-Mediated Plasma Cell Formation and Is Deregulated in Common Variable Immunodeficiency-Derived B Cells
   J Immunol, 195 (6), 2601-11
   DOI 10.4049/jimmunol.1500250, PubMed 26276871
2. Li J, Jørgensen SF, Maggadottir SM, Bakay M, Warnatz K, Glessner J, Pandey R, Salzer U, Schmidt RE, Perez E, Resnick E, Goldacker S, Buchta M, Witte T, Padyukov L, Videm V, Folseraas T, Atschekzei F, Elder JT, Nair RP, Winkelmann J, Gieger C, Nöthen MM, Büning C, Brand S et al. (2015)
   Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells
   Nat Commun, 6, 6804
   DOI 10.1038/ncomms7804, PubMed 25891430

Publications 2013

1. Gregersen S, Holm AM, Fevang B, Ueland T, Sikkeland LI, Aaløkken TM, Mynarek G, Kongerud J, Aukrust P, Johansen B, Frøland SS (2013)
   Lung disease, T-cells and inflammation in common variable immunodeficiency disorders
   Scand J Clin Lab Invest, 73 (6), 514-22
   DOI 10.3109/00365513.2013.819523, PubMed 23957371
2. Indrevær RL, Holm KL, Aukrust P, Osnes LT, Naderi EH, Fevang B, Blomhoff HK (2013)
   Retinoic acid improves defective TLR9/RP105-induced immune responses in common variable immunodeficiency-derived B cells
   J Immunol, 191 (7), 3624-33
   DOI 10.4049/jimmunol.1300213, PubMed 24006462

Publications 2012

1. Smedbakken LM, Halvorsen B, Daissormont I, Ranheim T, Michelsen AE, Skjelland M, Sagen EL, Folkersen L, Krohg-Sørensen K, Russell D, Holm S, Ueland T, Fevang B, Hedin U, Yndestad A, Gullestad L, Hansson GK, Biessen EA, Aukrust P (2012)
   Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization
   Atherosclerosis, 224 (1), 266-73
   DOI 10.1016/j.atherosclerosis.2012.06.071, PubMed 22840692

Publications 2010

1. Gregersen S, Aaløkken TM, Mynarek G, Fevang B, Holm AM, Ueland T, Aukrust P, Kongerud J, Johansen B, Frøland SS (2010)
   Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors
   Ann Allergy Asthma Immunol, 104 (6), 503-10
   DOI 10.1016/j.anai.2010.04.015, PubMed 20568383

Publications 2009

1. Damås JK, Landrø L, Fevang B, Heggelund L, Frøland SS, Aukrust P (2009)
   Enhanced levels of the CCR7 ligands CCL19 and CCL21 in HIV infection: correlation with viral load, disease progression and response to highly active antiretroviral therapy
   AIDS, 23 (1), 135-8
   DOI 10.1097/QAD.0b013e32831cf595, PubMed 19050397
2. Fevang B, Eugen-Olsen J, Yndestad A, Brosstad F, Beiske K, Aukrust P, Frøland SS (2009)
   Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency
   Clin Immunol, 131 (3), 438-46
   DOI 10.1016/j.clim.2009.01.007, PubMed 19232508

Publications 2008

1. Dahl CP, Gullestad L, Fevang B, Holm AM, Landrø L, Vinge LE, Fiane AE, Sandberg WJ, Otterdal K, Frøland SS, Damås JK, Halvorsen B, Aukrust P, Øie E, Yndestad A (2008)
   Increased expression of LIGHT/TNFSF14 and its receptors in experimental and clinical heart failure
   Eur J Heart Fail, 10 (4), 352-9
   DOI 10.1016/j.ejheart.2008.02.010, PubMed 18353719
2. Fevang B, Yndestad A, Damås JK, Bjerkeli V, Ueland T, Holm AM, Beiske K, Aukrust P, Frøland SS (2008)
   Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation
   Clin Immunol, 130 (2), 151-61
   DOI 10.1016/j.clim.2008.09.002, PubMed 18938112
3. Smith C, Halvorsen B, Otterdal K, Waehre T, Yndestad A, Fevang B, Sandberg WJ, Breland UM, Frøland SS, Oie E, Gullestad L, Damås JK, Aukrust P (2008)
   High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins
   Cardiovasc Res, 79 (1), 195-203
   DOI 10.1093/cvr/cvn071, PubMed 18339644

Publications 2007

1. Bjerkeli V, Damås JK, Fevang B, Holter JC, Aukrust P, Frøland SS (2007)
   Increased expression of fractalkine (CX3CL1) and its receptor, CX3CR1, in Wegener's granulomatosis--possible role in vascular inflammation
   Rheumatology (Oxford), 46 (9), 1422-7
   DOI 10.1093/rheumatology/kem168, PubMed 17616549

Publications 2006

1. Damås JK, Smith C, Øie E, Fevang B, Halvorsen B, Waehre T, Boullier A, Breland U, Yndestad A, Ovchinnikova O, Robertson AK, Sandberg WJ, Kjekshus J, Taskén K, Frøland SS, Gullestad L, Hansson GK, Quehenberger O, Aukrust P (2006)
   Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization
   Arterioscler Thromb Vasc Biol, 27 (3), 614-20
   DOI 10.1161/01.ATV.0000255581.38523.7c, PubMed 17170367